☆ 4.2 Article

In Vitro Drug Susceptibility of a Leishmania (Leishmania) infantum Isolate from a Visceral Leishmaniasis Pediatric Patient after Multiple Relapses

TROPICAL MEDICINE AND INFECTIOUS DISEASE (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

3′Nucleotidase/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine

Juliana B. T. Carnielli et al.

Summary: In Brazil, miltefosine treatment failure in visceral leishmaniasis has been linked to the deletion of the miltefosine susceptibility locus (MSL) in Leishmania infantum. CRISPR-Cas9 was used to investigate the role of NUC1, NUC2, HLP, and TEI in miltefosine resistance mechanisms. Findings suggest that the absence of NUC1 and NUC2 from the MSL contributes to natural resistance to miltefosine in L. infantum.

EBIOMEDICINE (2022)

Add to Collection

Article Parasitology

Isolation, typing, and drug susceptibility of Leishmania (Leishmania) infantum isolates from dogs of the municipality of Embu das Artes, an endemic region for canine leishmaniasis in Brazil

Bianca A. Ferreira et al.

Summary: The study confirmed the endemicity of canine leishmaniasis in Embu das Artes, Brazil, and found that isolates from this region are susceptible to paromomycin and miltefosine, indicating the potential of these drugs for the clinical treatment of human visceral leishmaniasis in Brazil.

PARASITOLOGY RESEARCH (2022)

Add to Collection

Article Parasitology

A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model

Fabiana Rodrigues de Santana et al.

Summary: This study evaluated the efficacy of treatment with a recombinant cysteine proteinase from Leishmania, rldccys1, combined with allopurinol or miltefosine in hamsters infected with Leishmania (Leishmania) infantum chagasi. The results showed a significant decrease in parasite load and lower levels of serum immunoglobulins in hamsters treated with the combination therapy. The treatment with miltefosine combined with rldccys1 also prevented relapse.

PARASITOLOGY RESEARCH (2022)

Add to Collection

Article Parasitology

Full nucleotide sequencing of ribosomal DNA internal transcribed spacer of Leishmania species causing cutaneous leishmaniasis in Brazil and its potential for species typing

Caroline R. Espada et al.

Summary: Species-specific diagnosis is a challenge in leishmaniasis management, especially in regions with multiple endemic species like Brazil. Clinical manifestations of cutaneous leishmaniasis in Brazil are complex, with different patterns identified. Nucleotide sequence analysis can successfully discriminate species within the Leishmania (Viannia) subgenus and determine their phylogenetic relationships.

ACTA TROPICA (2021)

Add to Collection

Article Biology

Colonization and genetic diversification processes of Leishmania infantum in the Americas

Philipp Schwabl et al.

Summary: This study revealed a multi-kilobase deletion in Brazilian Leishmania infantum genomes, which reduces susceptibility to the anti-leishmanial drug miltefosine. The research also showed that hybridization with non-deletion strains can restore the deleted locus and associated enzymatic activity, indicating common genetic exchange among closely related parasites. The findings suggest that genetic exchange and demographic scenarios play key roles in shaping the complex population structure of L. infantum in Brazil.

COMMUNICATIONS BIOLOGY (2021)

Add to Collection

Article Chemistry, Medicinal

Well-Tolerated Amphotericin B Derivatives That Effectively Treat Visceral Leishmaniasis

Christelle Morelle et al.

Summary: Chemotherapy for visceral leishmaniasis is limited, with liposomal Amphotericin B emerging as a first-line drug in many countries despite its cost. Research is focused on finding cheaper and stable formulations of AmB, as well as developing less-toxic derivatives. Two less-toxic AmB derivatives, particularly AmB-MU, show promising efficacy and tolerability in vitro, making them potential candidates for improving treatment of this prevalent parasitic disease.

ACS INFECTIOUS DISEASES (2021)

Add to Collection

Article Microbiology

In Vitro Susceptibility to Miltefosine of Leishmania infantum (syn. L. chagasi) Isolates from Different Geographical Areas in Brazil

Caroline Ricce Espada et al.

Summary: This study investigated the susceptibility of 73 Brazilian strains of Leishmania infantum to miltefosine, showing relatively low heterogeneity in miltefosine susceptibility. The results suggest that Brazilian L. infantum may not have decreased susceptibility to miltefosine, indicating the potential for future clinical evaluation of miltefosine for VL treatment in Brazil.

MICROORGANISMS (2021)

Add to Collection

Article Parasitology

Is splenectomy an option for multiple relapses in a child with visceral leishmaniasis? A case report

Marcos Adriano Garcia Campos et al.

Summary: Visceral leishmaniasis (VL) is an infectious disease caused by Leishmania spp. Recurrence of the disease is common in patients with decreased T-cell function, and splenectomy may be a therapeutic option in some cases but its effectiveness is still uncertain. This report details the case of a pediatric patient with seven recurrences of VL, who relapsed post-surgery after drug therapy and splenectomy.

REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2021)

Add to Collection

Article Parasitology

Activity of paromomycin against Leishmania amazonensis: Direct correlation between susceptibility in vitro and the treatment outcome in vivo

Elizabeth M. Coser et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Natural Resistance of Leishmania infantum to Miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil

Juliana B. T. Carnielli et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)

Add to Collection

Article Parasitology

Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case

Maria Antonia Ferreira Gomes et al.

REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2018)

Add to Collection

Article Parasitology

Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs

Alberto Rastrojo et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)

Add to Collection

Review Microbiology

Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives

Fabiana Alves et al.

CLINICAL MICROBIOLOGY REVIEWS (2018)

Add to Collection

Review Medicine, General & Internal

Leishmaniasis

Sakib Burza et al.

LANCET (2018)

Add to Collection

Article Medicine, General & Internal

A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis

Juliana B. T. Carnielli et al.

EBIOMEDICINE (2018)

Add to Collection

Article Parasitology

Leishmania infantum: illness, transmission profile and risk factors for asymptomatic infection in an endemic metropolis in Brazil

Leticia Helena Dos Santos Marques et al.

PARASITOLOGY (2017)

Add to Collection

Article Infectious Diseases

Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial

Gustavo Adolfo Sierra Romero et al.

PLOS NEGLECTED TROPICAL DISEASES (2017)

Add to Collection

Review Infectious Diseases

Drug resistance and treatment failure in leishmaniasis: A 21st century challenge

Alicia Ponte-Sucre et al.

PLOS NEGLECTED TROPICAL DISEASES (2017)

Add to Collection

Review Infectious Diseases

Leishmaniasis in immunosuppressed individuals

J. van Griensven et al.

CLINICAL MICROBIOLOGY AND INFECTION (2014)

Add to Collection

Review Infectious Diseases

Visceral leishmaniasis: host-parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host

Laura Saporito et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2013)

Add to Collection

Article Parasitology

(Post-) Genomic approaches to tackle drug resistance in Leishmania

Maya Berg et al.

PARASITOLOGY (2013)

Add to Collection

Article Immunology

Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use

Shyam Sundar et al.

CLINICAL INFECTIOUS DISEASES (2012)

Add to Collection

Article Infectious Diseases

Three new sensitive and specific heat-shock protein 70 PCRs for global Leishmania species identification

A. M. Montalvo et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)

Add to Collection

Article Parasitology

Splenectomy in a patient with treatment-resistant visceral leishmaniasis: a case report

Robson Azevedo Dutra et al.

REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2012)

Add to Collection

Article Infectious Diseases

Leishmania donovani Develops Resistance to Drug Combinations

Raquel Garcia-Hernandez et al.

PLOS NEGLECTED TROPICAL DISEASES (2012)

Add to Collection

Review Microbiology

Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?

Francois Chappuis et al.

NATURE REVIEWS MICROBIOLOGY (2007)

Add to Collection

Article Microbiology

Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes

K El Fadili et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

Add to Collection

Article Immunology

Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages

DS Zamboni et al.

INFECTION AND IMMUNITY (2003)

Add to Collection

Article Medicine, General & Internal

Oral miltefosine for Indian visceral leishmaniasis

S Sundar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.